Utah Fund of Funds
The width of the quote written here
will have to be controlled manually.

Utah Fund of Funds Current Portfolio

The Fund has made commitments to the following underlying Funds:


5 AM Ventures II, L.P. - $150 Million;
Fund II focuses on seed and early-stage investments in life sciences

Apax US VII, L.P. - $850 Million;
Fund VII focuses on buyouts in the retail & consumer, tech & telecom, healthcare, media and financial & business services industries

Clarus Ventures II, L.P. - $660 Million;
Fund II focuses on healthcare and life science companies

Cross Creek Capital, L.P. - $111 Million;
Fund I focuses on late-stage investments across a broad spectrum of industries

Fenway III - $702 million;
Buyout Fund focused on transportation logistics and brand development

Foundry I L.L.C. - $225 million;
Focused on seed and early stage information technology

Frazier Healthcare VI L.P. - $600 million;
Healthcare and biotechnology growth driven fund.

Highway 12 Ventures II, L.P. - $75 Million;
Fund II focuses on seed, early, and expansion stage investments across a broad spectrum of industries

Hummer Windblad IV, L.P. - $183 Million;
Focuses on SaaS technology, telecom and analytics.

Media Technology Venture V - $125 million;
Seed and early stage technology fund

Rosewood Capital V, L.P. - $295 Million;
Fund V focuses on growth capital in the consumer and business services industries

RWI Ventures II, L.P. - $65 Million;
Fund II focuses on multi-stage investments in the technology and healthcare industries

Shasta Venture Group II - $250 million;
Focused on seed and early stage information technology

Sorenson II - $400 million;
Focuses on small to mid-market buyouts as well as growth-equity investments in Mountain West region

SV Life Sciences Fund IV, L.P. - $550 Million;
Fund IV focuses on multi-stage investments in most life sciences industries

University Venture Fund - $18 Million;
Fund I is a co-investment fund focuses on seed and early-stage investments across a broad spectrum of industries

UV Partners III - $100 million;
Convergence style fund focusing on health care and technology

vSpring II, L.P. - $85 Million;
Fund II focuses on seed and early stage investments in the technology, life science, communications and business services industries